​

Kymera Therapeutics (KYMR) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Kymera Therapeutics Revenue Highlights

Latest Revenue (Y)

$47.07M

Latest Revenue (Q)

$11.48M

Kymera Therapeutics Revenue by Period

Kymera Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$47.07M-40.11%
2023-12-31$78.59M67.84%
2022-12-31$46.83M-35.71%
2021-12-31$72.83M114.00%
2020-12-31$34.03M1059.99%
2019-12-31$2.93M100.00%
2018-12-31--

Kymera Therapeutics generated $47.07M in revenue during NA 2024, up -40.11% compared to the previous quarter, and up 1604.36% compared to the same period a year ago.

Kymera Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$11.48M-48.07%
2025-03-31$22.10M198.89%
2024-12-31$7.39M97.65%
2024-09-30$3.74M-85.42%
2024-06-30$25.65M149.34%
2024-03-31$10.29M-78.52%
2023-12-31$47.88M912.80%
2023-09-30$4.73M-71.37%
2023-06-30$16.51M74.45%
2023-03-31$9.47M-41.35%
2022-12-31$16.14M68.98%
2022-09-30$9.55M-17.05%
2022-06-30$11.51M19.66%
2022-03-31$9.62M-37.01%
2021-12-31$15.28M-24.89%
2021-09-30$20.34M9.81%
2021-06-30$18.52M-0.98%
2021-03-31$18.70M46.28%
2020-12-31$12.79M-12.03%
2020-09-30$14.53M342.00%
2020-06-30$3.29M-4.08%
2020-03-31$3.43M87.02%
2019-12-31$1.83M92.95%
2019-09-30$950.00K-

Kymera Therapeutics generated $11.48M in revenue during Q2 2025, up -48.07% compared to the previous quarter, and up 111.56% compared to the same period a year ago.

Kymera Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$263.40M$22.40M
GLUEMonte Rosa Therapeutics$75.62M$84.93M
NRIXNurix Therapeutics$54.55M$44.06M
KYMRKymera Therapeutics$47.07M$11.48M
ITOSiTeos Therapeutics$35.00M-
FHTXFoghorn Therapeutics$22.60M$7.56M
CCCCC4 Therapeutics$20.76M-
RLAYRelay Therapeutics$10.01M$7.68M
RVMDRevolution Medicines--

KYMR Revenue FAQ

What is Kymera Therapeutics’s yearly revenue?

Kymera Therapeutics's yearly revenue for 2024 was $47.07M, representing a decrease of -40.11% compared to 2023. The company's yearly revenue for 2023 was $78.59M, representing an increase of 67.84% compared to 2022. KYMR's yearly revenue for 2022 was $46.83M, representing a decrease of -35.71% compared to 2021.

What is Kymera Therapeutics’s quarterly revenue?

Kymera Therapeutics's quarterly revenue for Q2 2025 was $11.48M, a -48.07% decrease from the previous quarter (Q1 2025), and a -55.26% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $22.1M, a 198.89% increase from the previous quarter (Q4 2024), and a 114.83% increase year-over-year (Q1 2024). KYMR's quarterly revenue for Q4 2024 was $7.39M, a 97.65% increase from the previous quarter (Q3 2024), and a -84.56% decrease year-over-year (Q4 2023).

What is Kymera Therapeutics’s revenue growth rate?

Kymera Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0.53%, and for the last 5 years (2020-2024) was 38.31%.